Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway
Authors:
- 21 February 2018
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 24, 1080-1088
Abstract
BACKGROUND:F-box protein 32 (FBXO32) (also known as atrogin-1), a member of the F-box protein family, was recently shown to be a transforming growth factor beta (TGF-β)/Smad4 target gene involved in regulating cell survival. It can be transcriptiona...Keywords
This publication has 36 references indexed in Scilit:
- Declining Death Rates Reflect Progress against CancerPLOS ONE, 2010
- Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancerLaboratory Investigation, 2010
- Transforming Growth Factor–β Regulates Mammary Carcinoma Cell Survival and Interaction with the Adjacent MicroenvironmentCancer Research, 2008
- Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signalingProceedings of the National Academy of Sciences, 2008
- The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicityJournal of Clinical Investigation, 2007
- Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cellsGenes & Development, 2007
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- Missense Mutations of MADH4 Clinical Cancer Research, 2004
- Decreased Smad4 expression in the transforming growth factor‐β signaling pathway during progression of esophageal squamous cell carcinomaCancer, 2002
- Signal Transduction by the TGF-β SuperfamilyScience, 2002